Tower Research Capital LLC (Trc) Ocuphire Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,088 shares of OCUP stock, worth $4,006. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,088
Previous 3,377
21.05%
Holding current value
$4,006
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding OCUP
# of Institutions
47Shares Held
5.21MCall Options Held
12.6KPut Options Held
1.8K-
Bios Capital Management, LP Fort Worth, TX2.48MShares$2.43 Million3.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA314KShares$307,7040.0% of portfolio
-
Voss Capital, LLC Houston, TX191KShares$187,1380.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il176KShares$172,2570.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...